Effect of Oral Posaconazole on Venetoclax Plasma Concentration and its Efficacy in Patients with Acute Myeloid Leukemia
Higher levels of BCL-2 expression at initial diagnosis may have adverse effects on the efficacy and prognosis of patients, and higher levels of venetoclax concentration may advance the time of adverse reactions in patients, thus adversely affecting event-free survival (EFS).
Authors
- Yingzhi He
- Mengqi Guo
- Yuxian Huang (ORCID: https://orcid.org/0000-0001-8555-2768)
- Dezhi Qiu
- Yinjie Qin
- Jingwen Du
Institutions
- Zhujiang Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Recent Patents on Anti-Cancer Drug Discovery
- Published
- 2025-01-10
- DOI
- https://doi.org/10.2174/0115748928330206241104161111
- Citations
- 1
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 1.77